These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26340460)

  • 1. Effects of profound hypoxemia on coagulation & fibrinolysis in normal individuals.
    Redford DT; Paidy SR; Steinbrenner EB; Nielsen VG
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):228-31. PubMed ID: 26340460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide.
    Matika RW; Nielsen VG; Steinbrenner EB; Sussman AN; Madhrira M
    ASAIO J; 2014; 60(6):716-21. PubMed ID: 25232771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Thromb Res; 2010 Jul; 126(1):68-73. PubMed ID: 20406708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Anesth Analg; 2010 Dec; 111(6):1347-52. PubMed ID: 21048101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of normobaric hypoxic exposure on coagulation as measured by thromboelastography.
    Coppel J; Gilbert-Kawai E; Bottomley T; Sugarman J; Martin D
    Thromb Res; 2019 Dec; 184():105-109. PubMed ID: 31715543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced coagulation at high altitude identified by thromboelastography.
    Martin DS; Pate JS; Vercueil A; Doyle PW; Mythen MG; Grocott MP;
    Thromb Haemost; 2012 Jun; 107(6):1066-71. PubMed ID: 22437051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of beta-adrenergic blockade upon baseline blood coagulation and fibrinolytic activity and upon the responses to venous occlusion.
    Butler MJ; Smith M; Irving MH; Gordon YB; Ratky SM; Rivers JW; Hawkey C
    Thromb Diath Haemorrh; 1975 Sep; 34(1):169-80. PubMed ID: 1188710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon monoxide releasing molecule-2 enhances coagulation and attenuates fibrinolysis by two mechanisms: insights gained with colloid dilution.
    Cohen JB; Persaud JM; Malayaman SN; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):60-6. PubMed ID: 21157300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clot life span model analysis of clot growth and fibrinolysis in normal subjects: role of thrombin activatable fibrinolysis inhibitor.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):283-7. PubMed ID: 18469549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry.
    Brinkman AC; Romijn JW; van Barneveld LJ; Greuters S; Veerhoek D; Vonk AB; Boer C
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):422-6. PubMed ID: 20056447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide releasing molecule-2 improves protamine-mediated hypocoagulation/hyperfibrinolysis in human plasma in vitro.
    Nielsen VG; Malayaman SN; Cohen JB; Persaud JM
    J Surg Res; 2012 Apr; 173(2):232-9. PubMed ID: 20950825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The hemostasis system in hypoxic anoxia of varying degree].
    Pak GD; Sverchkova VS; Danilevskaia TN
    Kosm Biol Aviakosm Med; 1990; 24(2):4-9. PubMed ID: 2114503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of carbon dioxide in the correction of coagulation hemostasis during hypoxia].
    Pak GD; Sverchkova VS
    Kosm Biol Aviakosm Med; 1987; 21(6):43-7. PubMed ID: 3125377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain tumors enhance plasmatic coagulation: the role of hemeoxygenase-1.
    Nielsen VG; Lemole GM; Matika RW; Weinand ME; Hussaini S; Baaj AA; Steinbrenner EB
    Anesth Analg; 2014 May; 118(5):919-24. PubMed ID: 24413553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in blood coagulation of arm and leg veins during a simulated long-haul flight.
    Schobersberger W; Mittermayr M; Fries D; Innerhofer P; Klingler A; Faulhaber M; Gunga HC; Streif W
    Thromb Res; 2007; 119(3):293-300. PubMed ID: 16630648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of actomyosin on blood coagulation and fibrinolysis].
    Andreenko GV; Liutova LV
    Vopr Med Khim; 1976; 22(2):166-71. PubMed ID: 1030884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Features of blood coagulating and fibrinolytic properties under the action of epinephrine in hypoxia and hypercapnia].
    Pak GD; Sverchkov VS; Danilevskaia TN; Trandafilova TP
    Kosm Biol Aviakosm Med; 1988; 22(1):49-53. PubMed ID: 3361836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII.
    Nielsen VG; Kirklin JK
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):793-800. PubMed ID: 19002046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.